This post is part of a special report, A Dozen Ways to Play an Obama Building Boom.

"The world is focused on an infrastructure buildout, and one of the best ways to capture that trend is with Zurich-based infrastructure giant ABB (NYSE: ABB)," says Keith Fitz-Gerald.

In The Money Map Report, he explains, "We've been recommending the stock throughout this crisis; and while its up 50% off its low, we believe the best is still to come."

"Chances are you'll be hearing a lot of talk about it in the years to come as governments around the world initiate massive domestic fixed asset programs to create jobs, and improve critical services such as power distribution.

"President-elect Obama is focused on infrastructure while China's $586 billion stimulus package is also aimed at infrastructure building.

"World leaders recognize that the one thing they need, that they can't afford to lose, and that their people can't do without, is power. And lots of it. And one of the best ways to capture that is with Zurich-based ABB.

"You may not have your eye on Alcon Inc. (NYSE: ACL), but if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought ACL products," notes global expert Frida Ghitis.

Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has with its eyes on both the bottom line and the pipeline.

"As the world's largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownership structure.

"Demographics bode well. Aging eyes need attention. Demand will rise for glaucoma medication, dry eye treatments, and other Alcon top sellers. As emerging markets grow their middle class, eye-care will be affordable by millions more people.